Author:
Wang Huasong,Liu Linlin,Gou Mo,Huang Guian,Tian Chenglei,Yang Jiao,Wang Haiying,Xu Qin,Xu Guo_Liang,Liu Lin
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Drug Discovery,Biochemistry,Biotechnology
Reference15 articles.
1. Cimmino L, Dolgalev I, Wang Y, Yoshimi A, Martin GH, Wang J, Ng V, Xia B, Witkowski MT, Mitchell-Flack M et al (2017) Restoration of TET2 function blocks aberrant self-renewal and leukemia progression. Cell 170(1079–1095):e1020
2. Dawlaty MM, Breiling A, Le T, Raddatz G, Barrasa MI, Cheng AW, Gao Q, Powell BE, Li Z, Xu M et al (2013) Combined deficiency of Tet1 and Tet2 causes epigenetic abnormalities but is compatible with postnatal development. Dev Cell 24:310–323
3. Delhommeau F, Dupont S, Della Valle V, James C, Trannoy S, Masse A, Kosmider O, Le Couedic JP, Robert F, Alberdi A et al (2009) Mutation in TET2 in myeloid cancers. N Engl J Med 360:2289–2301
4. Ferrone CK, Blydt-Hansen M, Rauh MJ (2020) Age-associated TET2 mutations: common drivers of myeloid dysfunction. Cancer and cardiovascular disease. Int J Mol Sci 21:626
5. Hon GC, Song CX, Du T, Jin F, Selvaraj S, Lee AY, Yen CA, Ye Z, Mao SQ, Wang BA et al (2014) 5mC oxidation by Tet2 modulates enhancer activity and timing of transcriptome reprogramming during differentiation. Mol Cell 56:286–297
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献